Total Payments
$722.23
2023 Payments
$20.11
Companies
13
Transactions
39
Medicare Patients
971
Medicare Billing
$115,620
Payment Breakdown by Category
Food & Beverage$722.23 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $722.23 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $229.69 | 17 | $0 (2019) |
| Ceribell, Inc. | $95.90 | 1 | $0 (2019) |
| UCB, Inc. | $89.31 | 4 | $0 (2019) |
| Boston Scientific Corporation | $57.16 | 4 | $0 (2020) |
| Chiesi USA, Inc. | $51.85 | 1 | $0 (2019) |
| Lilly USA, LLC | $46.49 | 3 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $36.26 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $28.81 | 2 | $0 (2018) |
| Greenwich Biosciences, Inc. | $23.72 | 1 | $0 (2019) |
| Abbott Laboratories | $20.11 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.11 | 1 | Abbott Laboratories ($20.11) |
| 2022 | $28.77 | 2 | Biohaven Pharmaceutical Holding Company Ltd. ($16.87) |
| 2021 | $48.68 | 3 | Lilly USA, LLC ($34.59) |
| 2020 | $45.01 | 3 | Boston Scientific Corporation ($45.01) |
| 2019 | $342.44 | 13 | Ceribell, Inc. ($95.90) |
| 2018 | $93.65 | 6 | Genentech USA, Inc. ($44.41) |
| 2017 | $143.57 | 11 | Genentech USA, Inc. ($120.07) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2023 | Abbott Laboratories | AMPLATZER TALISMAN (Device) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Structural Heart | ||||||
| 05/25/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Neuroscience | ||||||
| 03/30/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: PRIMARY CARE | ||||||
| 05/14/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Neuroscience | ||||||
| 04/16/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Neuroscience | ||||||
| 03/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: PRIMARY CARE | ||||||
| 09/16/2020 | Boston Scientific Corporation | SUPERION (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/11/2020 | Boston Scientific Corporation | SUPERION (Device) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/04/2020 | Boston Scientific Corporation | SUPERION (Device) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/30/2019 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $51.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2019 | Ceribell, Inc. | — | Food and Beverage | Cash or cash equivalent | $95.90 | General |
| Category: Neurology | ||||||
| 10/15/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: Neurology | ||||||
| 10/10/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Neurology | ||||||
| 08/15/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2019 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Neurology | ||||||
| 07/09/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Metabolism & Primary Care | ||||||
| 06/20/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Metabolism & Primary Care | ||||||
| 06/11/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Metabolism & Primary Care | ||||||
| 06/03/2019 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Neurology | ||||||
| 03/14/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: CNS | ||||||
| 03/12/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Metabolism & Primary Care | ||||||
| 02/19/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Metabolism & Primary Care | ||||||
| 12/18/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/18/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Metabolism & Primary Care | ||||||
| 06/20/2018 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 251 | 297 | $92,520 | $26,662 |
| 2022 | 7 | 248 | 337 | $95,811 | $28,741 |
| 2021 | 7 | 257 | 330 | $98,555 | $31,671 |
| 2020 | 6 | 215 | 285 | $84,873 | $28,546 |
Total Patients
971
Total Services
1,249
Medicare Billing
$115,620
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 50 | $25,000 | $6,593 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 72 | $18,468 | $6,512 | 35.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 26 | $14,724 | $4,214 | 28.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 50 | $8,876 | $3,006 | 33.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 45 | 50 | $10,350 | $2,084 | 20.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $6,079 | $1,831 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $6,558 | $1,699 | 25.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 17 | 17 | $2,465 | $723.01 | 29.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 95 | $24,510 | $7,697 | 31.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 46 | $23,000 | $7,072 | 30.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 86 | $15,394 | $4,754 | 30.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 24 | $13,200 | $3,948 | 29.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $9,180 | $2,695 | 29.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 40 | 44 | $8,352 | $1,912 | 22.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 15 | 15 | $2,175 | $664.05 | 30.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 69 | 70 | $35,000 | $11,040 | 31.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 29 | 39 | $21,450 | $7,275 | 33.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 43 | 69 | $17,802 | $5,659 | 31.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 68 | $12,172 | $3,924 | 32.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 44 | 49 | $7,056 | $2,166 | 30.7% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 20 | 20 | $2,900 | $918.60 | 31.7% |
| 95822 | Measurement and recording of brain wave (eeg) activity, in coma or asleep | Facility | 2021 | 13 | 15 | $2,175 | $688.95 | 31.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 68 | 108 | $23,652 | $8,940 | 37.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 46 | 47 | $19,237 | $7,565 | 39.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 31 | 42 | $28,400 | $7,407 | 26.1% |
About Dr. Seth Larson, MD
Dr. Seth Larson, MD is a Neurology healthcare provider based in Sun City, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255302352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seth Larson, MD has received a total of $722.23 in payments from pharmaceutical and medical device companies, with $20.11 received in 2023. These payments were reported across 39 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($722.23).
As a Medicare-enrolled provider, Larson has provided services to 971 Medicare beneficiaries, totaling 1,249 services with total Medicare billing of $115,620. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Sun City, AZ
- Active Since 01/28/2006
- Last Updated 02/08/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1255302352
Products in Payments
- Activase (Biological) $229.69
- CLEVIPREX (Drug) $51.85
- Briviact (Drug) $49.78
- EMGALITY (Drug) $46.49
- SUPERION (Device) $45.01
- Vimpat (Drug) $39.53
- APTIOM (Drug) $36.26
- NURTEC ODT (Drug) $30.96
- XARELTO (Drug) $28.81
- Epidiolex (Drug) $23.72
- AMPLATZER TALISMAN (Device) $20.11
- GENERAL - PAIN MANAGEMENT (Device) $12.15
- ELIQUIS (Drug) $11.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Sun City
Dr. David Shprecher, D.o, D.O
Neurology — Payments: $404,947
Neurology $404,947
Holly Laub, Do, DO
Neurology — Payments: $36,188
Neurology $36,188
Dr. Maninder Kahlon, M.d, M.D
Neurology — Payments: $20,855
Neurology $20,855
Sara Dhanani, M.d, M.D
Neurology — Payments: $17,103
Neurology $17,103
Dr. Brandon Woods, Md, MD
Neurology — Payments: $8,386
Neurology $8,386
Dr. Kenneth Harris, Md, MD
Neurology — Payments: $48.99
Neurology $48.99